Status:
COMPLETED
Plantar Fasciitis and the Use of Orthotics as Treatment
Lead Sponsor:
Talita Cumi Ltd.
Collaborating Sponsors:
Aetrex Worldwide Inc
Conditions:
Plantar Fascitis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
To investigate whether the use of prefabricated Orthotics in shoes, in combination with the use of indoor comfort sandals with built-in arch support, benefits the treatment of plantar fasciitis more t...
Detailed Description
The usual symptom of plantar fasciitis is "first-step pain", though plantar heel pain in general can be broadly associated with plantar fasciitis. Although most of the cases resolve within 10 months, ...
Eligibility Criteria
Inclusion
- Have been experiencing symptoms of Plantar Fasciitis for at least 2 months. A diagnosis of plantar fasciitis will be made on the criteria that the pain is located on the medial aspect of the heel on palpation and the pain is worst the first thing in the morning.
- Aged 19-75 years old
Exclusion
- Prior operations on the foot,
- Prior treatments apart from analgesia in the last 12 months e.g. corticosteroid injections,
- Congenital or acquired foot and ankle abnormalities which prevent the use of normal footwear.
Key Trial Info
Start Date :
July 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04894383
Start Date
July 23 2021
End Date
January 31 2023
Last Update
May 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Talita Cumi LTD.
Southport, Merseyside, United Kingdom, PR8 3NS